Literature DB >> 16176832

Mononuclear metal complexes with piroxicam: synthesis, structure and biological activity.

Petros Christofis1, Maria Katsarou, Athanasios Papakyriakou, Yiannis Sanakis, Nikos Katsaros, George Psomas.   

Abstract

Piroxicam (=Hpir) is a non-steroidal anti-inflammatory and an anti-arthritic drug. VO(2+), Mn(2+), Fe(3+), MoO(2)(2+) and UO(2)(2+) complexes with deprotonated piroxicam have been prepared and characterized with the use of infrared, UV-Vis, nuclear magnetic resonance and electron paramagnetic resonance spectroscopies. The experimental data suggest that piroxicam acts as a deprotonated bidentate ligand in all complexes and is coordinated to the metal ion through the pyridine nitrogen and the amide oxygen. Molecular mechanics calculations in the gas state have been performed in order to propose a model for the Fe(3+), VO(2+) and MoO(2)(2+) complexes. Potential anticancer cytostatic and cytotoxic effects of piroxicam complexes with VO(2+), Mn(2+) and MoO(2)(2+) on human promyelocytic leukemia HL-60 cells have been investigated. Among all complexes, only VO(pir)(2)(H(2)O) clearly induces apoptosis after 24-h incubation, whereas piroxicam induces apoptosis after 57-h incubation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176832     DOI: 10.1016/j.jinorgbio.2005.07.020

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  4 in total

1.  Binding of Cu(II) complexes of oxicam NSAIDs to alternating AT and homopolymeric AT sequences: differential response to variation in backbone structure.

Authors:  Sreeja Chakraborty; Esha Sehanobish; Munna Sarkar
Journal:  J Biol Inorg Chem       Date:  2012-01-20       Impact factor: 3.358

2.  First ruthenium organometallic complex of antibacterial agent ofloxacin. Crystal structure and interactions with DNA.

Authors:  Iztok Turel; Jakob Kljun; Franc Perdih; Elena Morozova; Vladimir Bakulev; Nina Kasyanenko; Jo Ann W Byl; Neil Osheroff
Journal:  Inorg Chem       Date:  2010-10-26       Impact factor: 5.165

3.  Problems with molecular mechanics implementations on the example of 4-benzoyl-1-(4-methyl-imidazol-5-yl)-carbonylthiosemicarbazide.

Authors:  Agata Siwek; Katarzyna Swiderek; Stefan Jankowski
Journal:  J Mol Model       Date:  2011-05-28       Impact factor: 1.810

4.  Design, Synthesis, Docking Study and Biological Evaluation of 4-Hydroxy-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide Derivatives as Anti-HIV Agents.

Authors:  Ali Imani; Sepehr Soleymani; Rouhollah Vahabpour; Zahra Hajimahdi; Afshin Zarghi
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.